This message was posted by a user wishing to remain anonymous
Dear members,
Quanterix released a new version of their Nf-L kit called v2. In this new version, they have implemented a new type of beads but all the rest remain unchanged.
We have just completed the validation using version 1 of the kit but this kit is no longer available. We are considering a partial validation but are wondering about the extent of it. I would really appreciate your input.
Would 3 P&A runs be sufficient? Do we have to compare the 2 kits or only use v2 kits for this partial validation has no data from clinical samples has been yet generated?
Thank you.
Kind regards.